Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Open Access

Correction

Correction: Serum Biomarkers Associated with Clinical Outcomes Fail to Predict Brain Metastases in Patients with Stage IV Non-Small Cell Lung Cancers

  • The PLOS ONE Staff

Notice of Republication

The original Supporting Information files were published in error. The files were removed from the HTML and PDF versions of this article on March 11, 2016. The publisher apologizes for the error.

Reference

  1. 1. Li BT, Lou E, Hsu M, Yu HA, Naidoo J, Zauderer MG, et al. (2016) Serum Biomarkers Associated with Clinical Outcomes Fail to Predict Brain Metastases in Patients with Stage IV Non-Small Cell Lung Cancers. PLoS ONE 11(1): e0146063. pmid:26730601

Citation: The PLOS ONE Staff (2016) Correction: Serum Biomarkers Associated with Clinical Outcomes Fail to Predict Brain Metastases in Patients with Stage IV Non-Small Cell Lung Cancers. PLoS ONE 11(3): e0152450. https://doi.org/10.1371/journal.pone.0152450

Published: March 23, 2016

Copyright: © 2016 The PLOS ONE Staff. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.